| Tentative Program |
| Day -1: July(07, 2025) |
| |
Meeting Hall |
| 08:00-09:00 |
Registrations Open |
| 09:00-09:15 |
Opening Ceremony |
| Keynote Talks |
| Keynote |
Title: TFEB is a master regulator of tumor-associated macrophages in breast cancer |
| Daping Fan, University Of South Carolina, USA |
| |
| Keynote |
Title: Targeted Nanotherapy using CRISPR/Cas9 for Genetically Knocking down Highly Specific Genes for Basal-like Breast Cancer |
| Dipanjan Pan, The Pennsylvania State University, USA |
| |
|
| Keynote |
Title: Distinct Tumor Immune Responses to Nanosecond Pulsed Electric Fields (nsPEFs) Determine Immunity |
| Stephen Jack Beebe, Old Dominion University, USA |
| |
|
| |
Group Photo & Refreshment Break |
| SCIENTIFIC SESSION-I |
| |
|
| |
Title: Breast Cancer Eradication by Steroid Receptor Coactivator-3 Deleted Regulaotry T Cells |
| Sang Jun Han, Baylor College of Medicine, USA |
| |
|
| |
Title: Technological Innovations Enable the 24-hour Discharge of Patients Who Undergo Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction: Safety and Aesthetic Outcomes from A Single-Centre, Prospective Cohort Study |
| Zhenggui Du, West China Hospital of Sichuan University, Sofia, China |
| |
|
| |
SPEAKER SLOT AVAILABLE |
| |
| |
SPEAKER SLOT AVAILABLE |
| |
| |
Title: One stage single port endoscopic breast cancer reconstruction with Bra-flap technique and direct to implant : a four-year case series report of SmoothSilk implant |
| Tsung Chun Huang, China Medical University Hospital, Taiwan |
| |
|
| |
Title: Novel therapeutic approaches in development for hormone receptor-positive metastatic breast cancer |
| Richard Baird , China Medical University Hospital, UK |
| Networking & Panel Discussion |
| Lunch Break @ Restaurant |
| SCIENTIFIC SESSION-II |
| |
Title: Breast Cancer Screening in the Elderly United States Population: Challenges and Future Considerations |
| Jessica Burgers, Holy Cross Health, USA |
| |
|
| |
SPEAKER SLOT AVAILABLE |
| |
|
| |
Title: Factors Influencing Adherence to Endocrine Therapy After Breast Cancer Surgery |
| Aina Johnsson, Karolinska Institutet, Sweden |
| |
| |
SPEAKER SLOT AVAILABLE |
| |
|
| |
Title: Postoperative outcomes of minimally-invasive nipple-sparing mastectomy with immediate breast reconstruction versus conventional approach in women with early breast cancer – a single centre experience |
| Marc Ong Weijie, Khoo Teck Puat Hospital, Singapore |
| |
| |
SPEAKER SLOT AVAILABLE |
| |
|
| |
Title: Comparing Narrow and Wide Angle Digital Breast Tomosynthesis |
| Tanya W. Moseley, The University of Texas MD Anderson Cancer Center, USA |
| |
|
| |
SPEAKER SLOT AVAILABLE |
| |
|
| |
Title: "Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause a Nonapoptotic Cell Death, Oncosis, in Triple-Negative Breast Cancer Cell Lines with the causal involvement of the Ion Exchange Membrane Protein TRPM4.” |
| William C. Reinhold, National Institutes of Health, USA |
| |
|
| Refreshment Break |
| |
|
| |
Title: Clinico-genomic findings, molecular docking, and mutational spectrum in an understudied population with breast cancer patients from KP, Pakistan |
| Amna Mehmood, Martin Luther University Halle-Wittenberg, Germnay |
| |
|
| |
Title: Hypoxia modulates the XBP1s/HDAC2/EZH2-ΔNp63α axis to promote breast cancer metastasis independent of HIF1α |
| Zhixiong Jim Xiao, Sichuan University, China |
| |
|
| |
SPEAKER SLOT AVAILABLE |
| |
|
| Day-1 Concludes |
| If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org |